X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (87) 87
anti-cea antibody (76) 76
animals (73) 73
mice (69) 69
index medicus (61) 61
human colon-cancer (59) 59
mice, nude (50) 50
oncology (40) 40
carcinoembryonic antigen (38) 38
soft-tissue sarcoma (38) 38
female (36) 36
cell biology (34) 34
pdox (34) 34
salmonella-typhimurium a1-r (33) 33
carcinoembryonic antigen - immunology (32) 32
human pancreatic-cancer (27) 27
cancer (25) 25
colorectal cancer (25) 25
nude mice (25) 25
radioimmunotherapy (25) 25
male (24) 24
therapy (24) 24
surgery (23) 23
anti-cea antibodies (22) 22
nude-mice (22) 22
xenograft model antitumor assays (22) 22
tumors (20) 20
fluorescence-guided surgery (19) 19
immunoscintigraphy (19) 19
metastasis (19) 19
radiology, nuclear medicine & medical imaging (19) 19
cell line, tumor (18) 18
fluorescence (17) 17
neoplasm transplantation (17) 17
radioimmunodetection (17) 17
tumor (17) 17
aged (16) 16
analysis (16) 16
chemotherapy (16) 16
anti-cea (15) 15
article (15) 15
pancreatic cancer (15) 15
colorectal-cancer (14) 14
research paper (14) 14
xenografts (14) 14
antibodies, monoclonal (13) 13
biochemistry & molecular biology (13) 13
disease models, animal (13) 13
ewings-sarcoma (13) 13
middle aged (13) 13
nude-mouse model (13) 13
patient-derived orthotopic xenograft (13) 13
antibodies, monoclonal - therapeutic use (12) 12
cea (12) 12
efficacy (12) 12
imaging-system (12) 12
tissue distribution (12) 12
animal models (11) 11
antibodies (11) 11
antibodies, monoclonal - pharmacokinetics (11) 11
monoclonal antibodies (11) 11
monoclonal-antibodies (11) 11
orthotopic (11) 11
breast-cancer (10) 10
cells (10) 10
colorectal-carcinoma (10) 10
combination (10) 10
melanoma (10) 10
pharmacology & pharmacy (10) 10
subcutaneous ectopic model (10) 10
transplantation, heterologous (10) 10
tumor cells, cultured (10) 10
cancer therapies (9) 9
carcinoma (9) 9
doxorubicin (9) 9
fus-erg fusion (9) 9
health aspects (9) 9
heterografts (9) 9
precision medicine (9) 9
proteins (9) 9
recombinant methioninase (9) 9
resection (9) 9
salmonella typhimurium a1-r (9) 9
specimens (9) 9
anthracyclines (8) 8
anti-cea monoclonal antibody (8) 8
body weight (8) 8
colon cancer (8) 8
iodine radioisotopes - therapeutic use (8) 8
liver metastases (8) 8
neoplasm metastasis (8) 8
optical imaging (8) 8
recurrence (8) 8
sarcoma (8) 8
survival (8) 8
temozolomide (8) 8
antibodies, monoclonal - metabolism (7) 7
antigens (7) 7
drug-response (7) 7
gemcitabine (7) 7
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal of Surgical Oncology, ISSN 0022-4790, 12/2016, Volume 114, Issue 8, pp. 951 - 958
Journal Article
Journal Article
Journal of Controlled Release, ISSN 0168-3659, 11/2014, Volume 194, pp. 197 - 210
The bottlenecks of current chemotherapy in the treatment of colorectal cancer lie in the ineffectiveness of the existing anti-cancer small molecule drugs as... 
Protein transduction domain | Anti-CEA monoclonal antibody | Gelonin | Heparin | Cancer | CEA ANTIBODY | CELL-PENETRATING PEPTIDES | ANTITUMOR-ACTIVITY | CHEMISTRY, MULTIDISCIPLINARY | IN-VITRO | PHARMACOLOGY & PHARMACY | CARCINOEMBRYONIC ANTIGEN | RIBOSOME-INACTIVATING PROTEINS | PHASE-I | PROSPECTS | Humans | Ribosome Inactivating Proteins, Type 1 - therapeutic use | Antibodies, Monoclonal - therapeutic use | Male | Carcinoembryonic Antigen - metabolism | Drug Delivery Systems | Tissue Distribution | Antineoplastic Agents, Phytogenic - administration & dosage | Cell-Penetrating Peptides - therapeutic use | DNA Primers - administration & dosage | Colorectal Neoplasms - drug therapy | Antineoplastic Agents, Phytogenic - metabolism | Antineoplastic Agents, Phytogenic - therapeutic use | Gene Products, tat - chemistry | Xenograft Model Antitumor Assays | Maximum Tolerated Dose | Animals | Ribosome Inactivating Proteins, Type 1 - metabolism | Antibodies, Monoclonal - administration & dosage | Mice, Nude | Protein Binding | Mice | Antibodies, Monoclonal - metabolism | Genetic Vectors | Heparin - chemistry | Ribosome Inactivating Proteins, Type 1 - administration & dosage | Antimitotic agents | Viral antibodies | Chemotherapy | Glycosaminoglycans | Genetically modified organisms | Colorectal cancer | Antibodies | Genetic engineering | Antineoplastic agents | Health aspects
Journal Article
Journal Article
Oncotarget, ISSN 1949-2553, 12/2018, Volume 9, Issue 99, pp. 37333 - 37342
Pancreatic cancer is a highly lethal disease in part due to incomplete tumor resection. Targeting by tumor-specific antibodies conjugated with a fluorescent... 
Anti-CEA antibody | Patient derived orthotopic xenograft model | Pancreatic cancer | Fluorescence-guided surgery | LICOR IRDye800CW
Journal Article
BRITISH JOURNAL OF CANCER, ISSN 0007-0920, 06/2015, Volume 112, Issue 12, pp. 1882 - 1887
Background: We aimed to test the ability of texture analysis to differentiate the spatial heterogeneity of I-125-A5B7 anti-carcinoembryonic antigen antibody... 
single photon emission computed tomography | I-125-A5B7 anti-CEA antibody | RADIOIMMUNOTHERAPY | I-131-A5B7 | FEATURES | HETEROGENEITY | ONCOLOGY | IMAGES | CARCINOMAS | liver metastases | PET | texture analysis | tumour heterogeneity
Journal Article
British Journal of Cancer, ISSN 0007-0920, 06/2015, Volume 112, Issue 12, pp. 1882 - 1887
  Background:We aimed to test the ability of texture analysis to differentiate the spatial heterogeneity of 125 I-A5B7 anti-carcinoembryonic antigen antibody... 
Translational Therapeutics | 125I-A5B7 anti-CEA antibody | liver metastases | single photon emission computed tomography | texture analysis | tumour heterogeneity
Journal Article
Journal Article
ANNALS OF SURGERY, ISSN 0003-4932, 07/2019, Volume 270, Issue 1, pp. 21 - 22
Journal Article
Pharmaceutical Research, ISSN 0724-8741, 8/2015, Volume 32, Issue 8, pp. 2690 - 2703
To investigate the feasibility of applying PTD-modified ATTEMPTS (Antibody Targeted Triggered Electrically Modified Prodrug-Type Strategy) for enhanced toxin... 
Biochemistry, general | Biomedical Engineering | heparin | protein transduction domains | Biomedicine | anti-CEA monoclonal antibody | toxin | Pharmacy | Medical Law | cancer | Pharmacology/Toxicology | Toxin | Anti-CEAmonoclonal antibody | Protein transduction domains | Heparin | Cancer | SYSTEM | PROTEIN | TRANSDUCTION | CELL-PENETRATING PEPTIDES | ANTI-CEA ANTIBODY | CHEMISTRY, MULTIDISCIPLINARY | DELIVERY | PHARMACOLOGY & PHARMACY | T84.66 | CARCINOEMBRYONIC ANTIGEN | EXPRESSION | GELONIN | Mutant Chimeric Proteins | Humans | Heparin - administration & dosage | Heparin - therapeutic use | Antineoplastic Agents - therapeutic use | Signal Transduction - genetics | Ribosome Inactivating Proteins, Type 1 - pharmacology | Prodrugs - metabolism | Carcinoembryonic Antigen - metabolism | Drug Delivery Systems | Tissue Distribution | Xenograft Model Antitumor Assays | Animals | Proteins - metabolism | Mice, Nude | Cell Line, Tumor | Protamines - administration & dosage | Signal Transduction - physiology | Antineoplastic Agents - pharmacology | Mice | Protamines - therapeutic use | Drugs | Drug delivery systems | Care and treatment | Biological products | Glycosaminoglycans | Oncology, Experimental | Monoclonal antibodies | Anticoagulants (Medicine) | Research | Health aspects | Vehicles | Studies | Immunoglobulins | Toxins | Cancer therapies | Anti-CEA monoclonal antibody
Journal Article
Journal Article
Journal Article